24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biotech
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:21
Empathy CEO: "We help those who experienced loss get back on their feet"
09:20
Twinnovation connects Israeli startups with European partners amid tensions
09:00
FakeReporter CEO: "Disinformation is destroying the world"
08:39
"Israeli entrepreneurs are some of the best in the world and are poised to take advantage of 2025"
More stories
Buzz
Most popular
Daily
Weekly
1
NetApp sells Spot to Flexera for $100 million, four years after $450 million acquisition
2
Lenovo acquires enterprise storage company Infinidat in its first Israeli acquisition
3
Warburg Pincus Signs Deal to Acquire Israeli Credit Card Issuer for $680 Million
4
Spot.io founder nets $7 million Seed round to tackle cloud chaos with new startup
5
eToro files for US IPO, targeting $5 billion valuation
More news
Biotech
20 stories about Biotech
CBI plans to issue new SPAC to merge with Israeli life science company
18.03.21
|
Hezi Sternlicht
The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
ForeBio is on its way to Nasdaq at a $500 million valuation
01.03.21
|
Tzally Greenberg
The company aims to raise $100 million in an April IPO, while Pontifax and OrbiMed who previously invested $21 million for a 12.5% stake in ForeBio’s shares are expected to make a $120 million profit
"Our nasal spray is like a hand sanitizer for your nose and can block 99.9% of Covid-19 viruses," says CEO
13.01.21
|
Yafit Ovadia
After new Covid-strains emerge, SaNOtize’s nasal spray is being used in clinical trials in the U.K. and Canada, with plans to be rolled out in the U.S. soon
Startup+ Competition: These startups create innovative products for everyday use
14.12.20
|
Meir Orbach
Reducing the risk of bodies’ rejecting implants, easy-to-use information about real estate data, and a support network for abused women are just some of the tech solutions featured in Calcalist’s Startup+ competition that can be used every day
Tech in your toilet: OutSense raises $2.2 million for device that tests poo for health risks
09.11.20
|
James Spiro
Attaching its IoT device to a toilet bowl, bathroom visitors can help catch cancers and other diseases, company aims to create the world’s largest database of human waste
“This is a great opportunity to secure ties and relationships with our cousins in Israel,” says Emirati executive
01.11.20
|
CTech
"I have seen a lot of projects built on trust in the past and today they are worth billions," says Farid Al Zarooni chairman of AngelWorld BioTech
MeMed analyzes complex immune responses to answer simple health questions
26.10.20
|
Yafit Ovadia
Growing biotechnology company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers
Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold
12.10.20
|
Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
Biological cancer treatment company Novellus raises $57 million
22.09.20
|
Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
Immunai Announces $20 Million Seed Round to Fund Immune System Mapping
14.05.20
|
Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies
Biomed Company CartiHeal Considers a Nasdaq IPO
26.02.20
|
Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist
21.02.20
|
Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
Peregrine Ventures Raises Fourth $115 Million Fund
09.12.19
|
CTech
The Israeli medtech venture firm now has over $200 million under management
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch
29.10.19
|
Sophie Shulman
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO
15.10.19
|
CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech
03.10.19
|
Ori Galor and Tzally Greenberg
The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma fell through
New York-Based Financial Services Firm Jefferies to Join Tel Aviv Stock Exchange
02.06.19
|
Raheli Bindman
As a remote member, Jefferies’ international clients will gain better access to Israeli tech and biotech companies, creating more investment opportunities
RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund
09.04.19
|
CTech
The fund's portfolio is made up of 11 startups operating at the company’s FutuRx biotech accelerator in the central Israeli town of Ness Ziona
Can-Fite BioPharma to Raise $3.2 Million in Direct Offering
04.04.19
|
CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million
28.03.19
|
Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
Previous Articles
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility